NCT06455293View on ClinicalTrials.gov

Psilocybin Therapy for Depression in Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions
Parkinson DiseaseDepression
Interventions
DRUG

Psilocybin

"Single dose of psilocybin ranging from low (microdose) to high delivered orally with psychological support and monitoring"

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

Joshua Woolley, MD, PhD

OTHER